Groups information

Group name

TBx patients

Groups remarks

targeted prostate biopsy

Clinical T stage

T1c

84 (34.2%)

T2

28 (11.5%)

T3

13 (5.3%)

remark

Clinical stage, n (%)

N stage, M stage